Home|Journals|Articles by Year|Audio Abstracts
 

Research Article



Retrospective study of 311 cases of Staphylococcus aureus bacteraemia with vascular access devices compared to ethnicity: Incidence in Waikato New Zealand from 2008-2018

Lynette Joy Lennox, Jenny Heretini.




Abstract
Cited by 0 Articles

Aim:
To document retrospectively whether New Zealand (NZ) Māori have a higher incidence of health associated (HA)staphylococcus aureus bacteraemia (SAB) with a vascular-access-device (VAD) compared to other ethnicities in Waikato District Health Board (WDHB).
Methods:
From the 1 January 2008 to 31 December 2018, all ages of inpatients with a VAD HA-SAB in one District Health Board (DHB) were retrospectively studied. All data was obtained from the Infection Prevention and Control (IPC) SAB records and analysed.
Results:
The study period of eleven years identified 311 VAD HA-SABs. The overall statistical hypothesis testing of VAD HA-SABs were P=0.175. A greater proportion of VAD HA-SABs occurred in the renal population at a rate of 35.7% (111). Renal representation of ethnic groups with a VAD HA-SAB were Non-NZ Māori 52.86% and Māori 47.14%. Peripheral VAD had greater percentage of incidence of VAD HA-SAB.
Conclusions:
Māori renal patients with VAD’s in WDHB experienced increased incidence of HA-SABs from 2008-2018 in comparison to other ethnic populations. Māori renal patients are 3 ½ times more likely to suffer VAD HA-SAB than Non-Māori patients. NZ data for VAD HA-SABS requires IPC teams to include ethnicity and provide a standardised, correct diagnosis of a VAD HA-SABS. NZ health strategies need to ask well directed questions in order to progress toward equitable health outcomes.

Key words: Vascular access device, Staphylococcus aureus, Bacteraemia, Indigenous, Māori.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.